-
Jonathan Kaufman, MD; Emory University Winship Cancer Institute; #DDHO2022
17:41
-
Craig Hofmeister, MD, MPH; Emory University Winship Cancer Institute; #DDHO2022
10:06
-
Ajay Nooka, MD; Emory University Winship Cancer Institute; #DDHO2022
12:22
-
Kenneth Anderson, MD; Dana-Farber Cancer Institute; #DDHO2022
18:20
-
Nisha Joseph, MD; Emory University Winship Cancer Institute; #DDHO2022
7:26
-
Virtual Challenging Case Clinic: Multiple Myeloma_Updates from ASCO and EHA_Suzanne Lentzsch, MD, PhD
50:00
-
Current and emerging data for antibody-drug conjugates, bispecific antibodies, and CAR T-cell therapies in patients with MM_Kenneth Anderson; #BeyondASCO
14:11
-
Sequencing of novel therapies in relapsed/refractory MM_Maria-Victoria Mateos, MD, PhD; #BeyondASCO
10:22
-
Virtual Challenging Case Clinic: Multiple Myeloma_CAR T-cell Therapy: For Whom and When_NIna Shah, MD
47:28
-
MM-associated AL Amyloidosis_Shaji Kumar, MD
53:27
-
How to Integrate Novel Approaches in the Treatment of Relapsed/Refractory Myeloma_Suzanne Lentzch, MD, PhD; #hemeupdates2022
15:29
- Next Page
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company